Gene therapy for color blindness is an experimental gene therapy aiming to convert congenitally colorblind individuals to trichromats by introducing a photopigment gene that they lack. Though partial color blindness is considered only a mild disability and is controversial whether it is even a disorder, it is a condition that affects many people, particularly males. Complete color blindness, or achromatopsia, is very rare but more severe. While never demonstrated in humans, animal studies have shown that it is possible to confer color vision by injecting a gene of the missing photopigment using gene therapy. As of 2018 there is no medical entity offering this treatment, and no clinical trials available for volunteers.

Property Value
dbo:abstract
  • Gene therapy for color blindness is an experimental gene therapy aiming to convert congenitally colorblind individuals to trichromats by introducing a photopigment gene that they lack. Though partial color blindness is considered only a mild disability and is controversial whether it is even a disorder, it is a condition that affects many people, particularly males. Complete color blindness, or achromatopsia, is very rare but more severe. While never demonstrated in humans, animal studies have shown that it is possible to confer color vision by injecting a gene of the missing photopigment using gene therapy. As of 2018 there is no medical entity offering this treatment, and no clinical trials available for volunteers. (en)
dbo:wikiPageEditLink
dbo:wikiPageExtracted
  • 2019-06-10 21:24:45Z (xsd:date)
dbo:wikiPageHistoryLink
dbo:wikiPageID
  • 27108706 (xsd:integer)
dbo:wikiPageLength
  • 16981 (xsd:integer)
dbo:wikiPageModified
  • 2019-05-27 09:18:58Z (xsd:date)
dbo:wikiPageOutDegree
  • 52 (xsd:integer)
dbo:wikiPageRevisionID
  • 899010840 (xsd:integer)
dbo:wikiPageRevisionLink
dbp:wikiPageUsesTemplate
dct:subject
rdf:type
rdfs:comment
  • Gene therapy for color blindness is an experimental gene therapy aiming to convert congenitally colorblind individuals to trichromats by introducing a photopigment gene that they lack. Though partial color blindness is considered only a mild disability and is controversial whether it is even a disorder, it is a condition that affects many people, particularly males. Complete color blindness, or achromatopsia, is very rare but more severe. While never demonstrated in humans, animal studies have shown that it is possible to confer color vision by injecting a gene of the missing photopigment using gene therapy. As of 2018 there is no medical entity offering this treatment, and no clinical trials available for volunteers. (en)
rdfs:label
  • Gene therapy for color blindness (en)
owl:sameAs
foaf:isPrimaryTopicOf
is foaf:primaryTopic of